Pfizer's legendary Viagra finally set to face cheaper competition in U.S. | FiercePharma
Bad news for Momenta and Pfizer is a blessing for Teva
Pfizer, Takeda Reach $2.15 Billion Settlement With Teva, Sun Pharma - WSJ
Mylan-Pfizer off-patent merger boosts Teva - Globes
New innovation lab brings together pharma, biotech giants for AI therapeutics | The Times of Israel
Pfizer, Teva running short on antibiotic azithromycin amid COVID-19 therapy hunt | FiercePharma
Pfizer gets $2.15 billion settlement
Pfizer wins Viagra patent battle against Teva
Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial | RAPS
Pfizer Looks to Fill Void for Chemo Drug After Teva Discontinues Its Generic Version | BioSpace
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel
Pfizer, Teva and Actavis Vie to Buy Ratiopharm - The New York Times
Pfizer links with Synthon on generic Copaxone - PMLiVE
Pfizer Reaches Settlement with Teva on Generic Viagra | IndustryWeek
Generic Drug Maker Teva Settles With Pfizer Over Patent Dispute, In Pharma Court Battle
Teva wins battle with Pfizer over Viagra patent | Managing Intellectual Property
Generic Viagra Half the Price Teva Pfizer
Better Big Pharma Dividend Stock: Pfizer Or Teva? | Seeking Alpha
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx | FiercePharma
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Innovation lab driven by AI formed by AstraZeneca, Merck, Pfizer and Teva
Pfizer in $2.15 Billion Settlement From Teva and Sun for Patent Infringement
Drug giants line up for Irish legal battle over patents - Independent.ie
Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com
